| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_28004acd7e780d5dbbdfc3dcb2980913
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4168db0d64c749f20145684f4720e984
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_07c0f6e0ce2788b31f4a0f5d0e1daebd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b96504becc8a0e53c52419a40d0f750a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_76bfd53db8cd738259282097308993f5 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-122
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-007
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0073 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-122 |
| filingDate |
1995-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8aafdb2d3a4fa0134840c701a68151a4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_76c5d7574b16a5ea6967d1a9865c99a7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_448c12b1f98b72007f72e301ba9b0633
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9137ab4e2a3f60855a5357b121fd122a |
| publicationDate |
1996-05-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-9613254-A1 |
| titleOfInvention |
Pharmaceutical composition comprising atovaquone |
| abstract |
The present invention provides a pharmaceutical composition comprising atovaquone and a non-protein pulmonary surfactant. Suitably the composition comprises 10 to 30 % atovaquone by weight and 70 to 90 % non-protein pulmonary surfactant. The composition is suitable for oral or pulmonary administration and provides atovaquone having improved bioavailability. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005037246-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005037246-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1712220-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9835660-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109640948-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7758886-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006108556-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EA-016072-B1 |
| priorityDate |
1994-10-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |